Pelthos Therapeutics Inc.
PTHS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | $7 | $7 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $2 | $1 | $1 | $0 |
| Enterprise Value | $9 | $8 | $7 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$7 | -$2 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$7 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -13.54 | -12.8 | -4.26 | -1 |
| % Growth | -5.8% | -200.5% | -326% | – |
| Operating Cash Flow | -$6 | -$1 | -$2 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$6 | -$1 | -$2 | – |